CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
Hong Kong · Delayed Price · Currency is HKD 0.6050
+0.0050 (0.83%)
Aug 21, 2026, 4:08 PM HKT
HKG:0775 Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 535.66 | 603.07 | 553.97 | 664.32 | 691.93 | 890.8 |
Trading Asset Securities | - | - | 17.24 | 11.84 | 12.19 | 11.67 |
Cash & Short-Term Investments | 535.66 | 603.07 | 571.21 | 676.16 | 704.13 | 902.47 |
Cash Growth | -32.86% | 5.58% | -15.52% | -3.97% | -21.98% | -7.13% |
Accounts Receivable | 1,160 | 966.8 | 904.81 | 893.69 | 942.44 | 842.94 |
Other Receivables | 29.87 | 36.44 | 192.13 | 73.29 | 50.9 | 56.32 |
Receivables | 1,190 | 1,003 | 1,097 | 966.98 | 993.34 | 899.26 |
Inventory | 1,377 | 1,230 | 1,157 | 1,205 | 1,285 | 1,254 |
Prepaid Expenses | - | 169.99 | 139.42 | 144.8 | 142.57 | 113.55 |
Total Current Assets | 3,102 | 3,007 | 2,965 | 2,992 | 3,125 | 3,169 |
Property, Plant & Equipment | 4,446 | 4,265 | 4,152 | 4,575 | 4,421 | 4,813 |
Long-Term Investments | 1,187 | 1,183 | 49.2 | 48.78 | 48.35 | 5.79 |
Goodwill | 2,676 | 2,790 | 2,704 | 2,780 | 2,766 | 2,817 |
Other Intangible Assets | 321.59 | 160.27 | 315.05 | 375.56 | 417.84 | 430.26 |
Long-Term Deferred Tax Assets | 53.18 | 47.55 | 75.09 | 58.04 | 77.81 | 72.04 |
Long-Term Deferred Charges | 379.28 | 383.03 | 399.79 | 417.51 | 411.37 | 423.64 |
Total Assets | 12,165 | 11,837 | 10,789 | 11,247 | 11,267 | 11,731 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 373.04 | 332.16 | 358.12 | 412.03 | 278.99 |
Accrued Expenses | - | 416.18 | 428.37 | 394.48 | 351.29 | 347.19 |
Current Portion of Long-Term Debt | 2,429 | 2,368 | 1,277 | 1,150 | 3,056 | 1,224 |
Current Portion of Leases | 97.32 | 80.44 | 73.74 | 71.78 | 69.42 | 69.11 |
Current Income Taxes Payable | 17.94 | 39.47 | 58.63 | 28.69 | 57.67 | 40.15 |
Current Unearned Revenue | - | 26.76 | 27.27 | 22.19 | 20.04 | 32.25 |
Other Current Liabilities | 849.36 | 163.99 | 116.52 | 75.3 | 95.53 | 83.41 |
Total Current Liabilities | 3,394 | 3,468 | 2,313 | 2,101 | 4,062 | 2,075 |
Long-Term Debt | 3,750 | 3,660 | 4,198 | 4,273 | 2,374 | 4,413 |
Long-Term Leases | 555.18 | 512.7 | 551.03 | 436.38 | 446.25 | 507.01 |
Pension & Post-Retirement Benefits | 11.47 | 10.97 | 10.29 | 9.7 | 8.14 | 11.41 |
Long-Term Deferred Tax Liabilities | 363.69 | 335.4 | 204.11 | 238.57 | 220.44 | 223.77 |
Other Long-Term Liabilities | - | 3.44 | - | - | - | - |
Total Liabilities | 8,074 | 7,990 | 7,277 | 7,058 | 7,111 | 7,230 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 961.11 | 961.11 | 961.11 | 961.11 | 961.11 | 961.11 |
Additional Paid-In Capital | 3,110 | 3,110 | 3,110 | 3,110 | 3,186 | 3,283 |
Retained Earnings | 1,941 | 1,970 | 2,210 | 2,337 | 2,320 | 2,187 |
Comprehensive Income & Other | -2,065 | -2,261 | -2,769 | -2,218 | -2,309 | -1,927 |
Total Common Equity | 3,947 | 3,780 | 3,512 | 4,189 | 4,158 | 4,504 |
Minority Interest | 143.21 | 66.46 | - | - | -2.75 | -2.74 |
Shareholders' Equity | 4,090 | 3,846 | 3,512 | 4,189 | 4,155 | 4,501 |
Total Liabilities & Equity | 12,165 | 11,837 | 10,789 | 11,247 | 11,267 | 11,731 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6,832 | 6,621 | 6,100 | 5,931 | 5,946 | 6,213 |
Net Cash (Debt) | -6,296 | -6,018 | -5,528 | -5,255 | -5,242 | -5,311 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.66 | -0.63 | -0.58 | -0.55 | -0.55 | -0.55 |
Filing Date Shares Outstanding | 9,611 | 9,611 | 9,611 | 9,611 | 9,611 | 9,611 |
Total Common Shares Outstanding | 9,611 | 9,611 | 9,611 | 9,611 | 9,611 | 9,611 |
Working Capital | -291.55 | -461.18 | 651.59 | 891.92 | -937.48 | 1,094 |
Book Value Per Share | 0.41 | 0.39 | 0.37 | 0.44 | 0.43 | 0.47 |
Tangible Book Value | 950.09 | 829 | 492.28 | 1,034 | 974.79 | 1,256 |
Tangible Book Value Per Share | 0.10 | 0.09 | 0.05 | 0.11 | 0.10 | 0.13 |
Land | 646.89 | 629.26 | 512.73 | 651.35 | 608 | 639.59 |
Machinery | 1,864 | 1,747 | 1,512 | 1,596 | 1,421 | 1,448 |
Construction In Progress | 165.37 | 160.01 | 220.3 | 188.38 | 210.83 | 134.32 |
Leasehold Improvements | 342.8 | 335.27 | 325 | 301.88 | 288.9 | 284.48 |